GHIT Fund Helping Pharmaceutical Companies To Develop NTD Treatments

Japan Times: Japanese drugmakers addressing neglected tropical diseases, and not just out of altruism
“…A total of one billion people are currently infected with NTDs, a major obstacle to development in poorer countries. To address the problem, the Global Health Innovative Technology (GHIT) Fund, a Japan-initiated organization, assists in the development of new drugs. … It has subsidized 30 new drug development programs, with six of them now in the clinical trial stage…” (1/6).